Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
After the initial consultation, we ship the prescription to your home
The average rebate on a brand name drug is ~50%, meaning patients pay double what the insurance plan pays for the drug
Key mechanistic features: Pulsatile GH release: Maintains natural GH secretion patterns rather than constant elevation Feedback preservation: Does not override normal hypothalamic-pituitary feedback loops IGF-1 elevation: Secondary increase in insulin-like growth factor-1 (IGF-1) through hepatic stimulation Lipolytic effects: Documented reduction in visceral adipose tissue (VAT) in clinical trials Tesamorelin FDA Approval History The Egrifta FDA approval timeline represents one of the few success stories for peptide therapeutics reaching market authorization
Biomedicine & Pharmacotherapy, 97 , 941947
US$ 22.24
US$ 27.61
US$ 24.81
US$ 25.44
US$ 24.93
